Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers.

MLA

Lillehammer, Trine, et al. “Melanoma-Specific Expression in First-Generation Adenoviral Vectors in Vitro and in Vivo -- Use of the Human Tyrosinase Promoter with Human Enhancers.” Cancer Gene Therapy, vol. 12, no. 11, Nov. 2005, pp. 864–72. EBSCOhost, https://doi.org/10.1038/sj.cgt.7700852.

APA

Lillehammer, T., Tveito, S., Engesaeter, B. O., Fodstad, O., Maelandsmo, G. M., & Engebraaten, O. (2005). Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers. Cancer Gene Therapy, 12(11), 864–872. https://doi.org/10.1038/sj.cgt.7700852

Chicago

Lillehammer, Trine, Siri Tveito, Birgit O Engesaeter, Oystein Fodstad, Gunhild M Maelandsmo, and Olav Engebraaten. 2005. “Melanoma-Specific Expression in First-Generation Adenoviral Vectors in Vitro and in Vivo -- Use of the Human Tyrosinase Promoter with Human Enhancers.” Cancer Gene Therapy 12 (11): 864–72. doi:10.1038/sj.cgt.7700852.